Risk of Hospital Encounters With Kidney Stones in Autosomal Dominant Polycystic Kidney Disease: A Cohort Study

被引:3
|
作者
Kalatharan, Vinusha [1 ]
Welk, Blayne [1 ,2 ]
Nash, Danielle M. [1 ,2 ]
Dixon, Stephanie N. [1 ,2 ]
Slater, Justin [2 ]
Pei, York [3 ]
Sarma, Sisira [1 ,2 ]
Garg, Amit X. [1 ,2 ,4 ]
机构
[1] Western Univ, Dept Epidemiol & Biostat, London, ON, Canada
[2] ICES, London, ON, Canada
[3] Univ Toronto, Univ Hlth Network, Toronto, ON, Canada
[4] Western Univ, Dept Med, Div Nephrol, London, ON, Canada
基金
加拿大健康研究院;
关键词
administrative data; autosomal dominant polycystic kidney disease; epidemiology; kidney stones; population health research; IDENTIFYING PATIENTS; PROGRESSION; EPIDEMIOLOGY; VALIDITY;
D O I
10.1177/20543581211000227
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: There is a perception that patients with autosomal dominant polycystic kidney disease (ADPKD) are more likely to develop kidney stones than the general population. Objective: To compare the rate of hospital encounter with kidney stones and the rate of stone interventions between patients with and without ADPKD. Design: Retrospective cohort study. Setting: Ontario, Canada. Patients: Patients with and without ADPKD who had a prior hospital encounter between 2002 and 2016. Measurements: Rate of hospital encounter with kidney stones and rate of stone intervention. Methods: We used inverse probability exposure weighting based on propensity scores to balance baseline indicators of health between patients with and without ADPKD. We followed each patient until death, emigration, outcomes, or March 31, 2017. We used a Cox proportional hazards model to compare event rates between the two groups. Results: Patients with ADPKD were at higher risk of hospital encounter with stones compared with patients without ADPKD (81 patients of 2094 with ADPKD [3.8%] vs 60 patients of 1902 without ADPKD [3.2%]; 8.9 vs 5.1 events per 1000 person-years; hazard ratio 1.6 [95% CI, 1.3-2.1]). ADPKD was not associated with a higher risk of stone intervention (49 of 2094 [2.3%] vs 47 of 1902 [2.4%]; 5.3 vs 3.9 events per 1000 person-years; hazard ratio 1.2 [95% CI = 0.9-1.3]). Limitations: We did not have information on kidney stone events outside of the hospital. There is a possibility of residual confounding. Conclusion: ADPKD was a significant risk factor for hospital encounters with kidney stones.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] The impact of asymptomatic kidney stones on disease progression in autosomal dominant polycystic kidney disease
    Elcioglu, Omer Celal
    Yatci, Beyza
    Ozturk, Burak Baris
    Mirioglu, Safak
    Gursu, Meltem
    Kazancioglu, Rumeyza
    BMC NEPHROLOGY, 2025, 26 (01)
  • [2] Kidney Stones Account for Increased Imaging Studies in Autosomal Dominant Polycystic Kidney Disease
    Simmons, Kathryn E.
    Ullman, Lawrence S.
    Dahl, Neera K.
    KIDNEY360, 2024, 5 (05): : 707 - 714
  • [3] Autosomal dominant polycystic kidney disease
    Chow, Chern Li
    Ong, Albert C. M.
    CLINICAL MEDICINE, 2009, 9 (03) : 278 - 283
  • [4] Autosomal dominant polycystic kidney disease
    Simms, Roslyn J.
    BMJ-BRITISH MEDICAL JOURNAL, 2016, 352
  • [5] Autosomal dominant polycystic kidney disease
    Lanktree, Matthew B.
    Chapman, Arlene B.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2017, 189 (45) : E1396 - E1396
  • [6] Autosomal Dominant Polycystic Kidney Disease
    Zacharia, George Sarin
    Rajakumari, P. K.
    JOURNAL OF PIONEERING MEDICAL SCIENCES, 2013, 3 (04): : 194 - 195
  • [7] AUTOSOMAL DOMINANT POLYCYSTIC DISEASE OF THE KIDNEY
    FICK, G
    WEBER, M
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1992, 117 (30) : 1160 - 1164
  • [8] Autosomal dominant polycystic kidney disease
    Silverman, Jonathan
    Desai, Chaitanya
    Lerma, Edgar V.
    DM DISEASE-A-MONTH, 2015, 61 (10): : 442 - 447
  • [9] Autosomal Dominant Polycystic Kidney Disease
    Pei, York
    Watnick, Terry
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2010, 17 (02) : 115 - 117
  • [10] Autosomal dominant polycystic kidney disease
    Pirson, Y
    Chauveau, D
    Watson, ML
    Zeier, M
    Breuning, MH
    M S-MEDECINE SCIENCES, 1997, 13 (01): : 37 - 44